› Forums › General Melanoma Community › Desperately seeking trial suggestions
- This topic has 3 replies, 2 voices, and was last updated 7 years, 3 months ago by
Bubbles.
- Post
-
- January 21, 2018 at 10:25 am
Based on the details below, I feel like I am so close to getting rid of this awful disease, but there doesnt seem to be a standard of care treatment that "fits" someone in my position (particularly when considering I do not want to have any side effects that would keep me from doing a clinical trial down the line.
I've been stage 4 since July 2016, and have been on Keytruda since then. I had a surgery to prevent bone fracture and radiation of the bone early in the course of treatment.
Ive had a very fortunate response to the Keytruda since, with large tumors on the Spleen and Lungs disappearing, and no new tumors showing up. I basically have 1 bone tumor in the pelvis that is nonresponsive, and 3 small liver lesions (1.6x.9 cm, 1.1x.6 cm, <.5cm) , which, while small, are in dangerous areas as far as the damage they could do to my body if they were to grow quickly.
I also have what appears to be a lesion in the pericardial space which has grown, and is currently the reason why we may channge therapies Keytruda. Thats also an area where a single, large tumor, could be deadly.
BOTTOM LINE: Does anyone know of any trials that work well for people who have responded well (and are still responding well) to PD-1 blockade, but which does not have the toxicities associated with adding ipi or doing TIL?
Any help at all would be deeply appreciated.
- Replies
-
-
- January 21, 2018 at 8:04 pm
Hi Anon, I think what would be helpful might be to get in contact with one of the big names in research who have a big picture view of the Melanoma landscape. A couple of names come to mind, Dr. Wolchok in NY and Dr. Omid Hamid at the Angeles Clinic, Dr. Jason Luke in Chicago and Dr. Allison at MD Anderson or anyone that is part of his team. Here is a link to some of the new ideas being investigated by Immunotherapy researchers discussed by Dr. Wolchok and a second link to CRI with some of their backed studies. Hope it helps!!!Ed https://www.youtube.com/watch?v=h2vs3lPPtBo https://www.cancerresearch.org/scientists/science-of-immunotherapy/cancer-types/melanoma
-
- January 21, 2018 at 8:54 pm
I am sorry for what you are dealing with. Predicting adverse effects and exclusions that trials may include at a later date is quite difficult. However, you don't mention your BRAF status. If BRAF positive, then targeted therapy may be something you could speak to your doc about. There are many studies with good results combining intralesional drugs with immunotherapy, though it doesn't sound as if you have injectable lesions. If those things are not options, I would look at trials that include drugs like atezolizumab or combine things like an IDO inhibitor (epacadostat), HDAC inhibitor (entinostat), or anti-LAG-3 (BMS986016) with immunotherapy. I will give you links (most with additional links within) to some abstracts and data I have posted. (However, MPIP only allow 2 links per post….so…. Here we go!)
Atezolizumab: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2017/06/asco-2017-atezo-anti-pdl1-with.html
IDO inhibitor: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2017/07/pembro-keytruda-and-epacadostat.html
more below….
-
- January 21, 2018 at 9:08 pm
To continue….
HDAC inhibitor: (this link includes several posts) http://chaoticallypreciselifeloveandmelanoma.blogspot.com/search?q=HDAC
Anti-LAG-3: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/search?q=anti-LAG-3
Perhaps these posts and related abstracts can help you familiarize yourself with possible options that you can discuss with your oncologist. I wish you my best. Celeste
-
- You must be logged in to reply to this topic.